Abstract
Background
The purpose of this study was to report our experience with sentinel lymph node dissection (SLND) for papillary thyroid carcinoma, to evaluate the feasibility and safety of the procedure, and to examine its potential utility as a guide for central neck dissection.
Materials and Methods
A retrospective chart review of patients undergoing total thyroidectomy from January 1998 thru January 2010 was conducted. Intratumoral injection of blue dye was used to identify the SLN. Central neck dissection (CND) was performed if the SLN was positive on frozen section. Locally advanced disease, previous thyroid surgery, or lymphadenopathy on preoperative imaging or intraoperative palpation were exclusion criteria.
Results
A total of 211 patients underwent SLN mapping. Of these, 165 patients (78%) were female and 46 (22%) were male. Also, 75 (36%) were ≤45 years of age, and 136 (64%) were older than 45. Tumors were ≤2.0 cm (T1) in 142 patients (67%), 2–4 cm (T2) in 35 patients (17%), >4 cm with minimal invasion (T3) in 32 patients (15%), and locally invasive (T4) in 2 patients (1%). At least 1 blue node was found in 192 patients (91%). Also, 47 patients had a positive SLN on frozen section, with an additional 24 node-positive patients on permanent section, for a total of 71 (37%). There were 43 patients (91%) who underwent central neck dissection; 26 (60%) had additional metastases.
Conclusions
Sentinel lymphadenectomy for papillary thyroid carcinoma is feasible, safe, and can identify patients who may benefit from central neck dissection.
Similar content being viewed by others
References
Noguchi M, Kumaki T, Taniya T, Miyazaki I. Bilateral cervical lymph node metastases in well differentiated thyroid cancer. Arch Surg. 1990;125:804–6.
Tisell LE, Nilsson B, Molne J, Hansson G, Fjälling M, Jansson S, et al. Improved survival of patients with papillary thyroid cancer after surgical microdissection. World J Surg. 1996;20:854–9.
Kelemen PR, Van Herle AJ, Giuliano AE. Sentinel lymphadenectomy in thyroid malignant neoplasms. Arch Surg. 1998;133:288–92.
Dixon E, McKinnon JG, Pasieka JL. Feasibility of sentinel lymph node biopsy and lymphatic mapping in nodular thyroid neoplasms. World J Surg. 2000;24:1396–401.
Fukui Y, Yamakawa T, Taniki T, Numoto S, Miki H, Monden Y. Sentinel lymph node biopsy inpatients with papillary thyroid carcinoma. Cancer. 2001;92:2868–74.
Takami H, Sasaki K, Ikeda Y, Tajima G, Kameyama K. Detection of sentinel lymph nodes in patients with papillary thyroid cancer. Asian J Surg. 2003;26:145–8.
Machens A, Hinze R, Thomusch O, Dralle H. Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg. 2002;26:22–8.
Toniato A, Boschin I, Casara D, Mazzarotto R, Rubello D, Pelizzo M. Papillary thyroid carcinoma: factors influencing recurrence and survival. Ann Surg Oncol. 2008;15:1518–22.
Chisholm EJ, Kulinskaya E, Tolley NS. Systematic review and meta-analysis of the adverse effects of thyroidectomy combined with central neck dissection as compared with thyroidectomy alone. Laryngoscope. 2009;119:1135–9.
Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167–214.
Pereira JA, Jimeno J, Miquel J, Iglesias M, Munné A, Sancho JJ, et al. Nodal yield, morbidity, and recurrence after central neck dissection for papillary thyroid carcinoma. Surgery. 2005;138:1095–100, discussion 100–1.
Roh JL, Park JY, Park CI. Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients: pattern of nodal metastasis, morbidity, recurrence, and postoperative levels of serum parathyroid hormone. Ann Surg. 2007;245:604–10.
Roh JL, Park CI. Sentinel lymph node biopsy as guidance for central neck dissection in patients with papillary thyroid carcinoma. Cancer. 2008;113:1527–31.
Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220:391–8; discussion 398–401.
Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392–9.
Turner RR. Histopathologic processing of the sentinel lymph node. Semin Breast Dis. 2002;27:1399–401.
Lester C. Thyroid and parathyroid glands, Chapter 34, Manual of Surgical Pathology. China: Elsevier Inc., 2006.
Edge SB, Compton CC. American Joint Committee on Cancer. 7th ed. New York: Springer-Verlag, 2009.
Clayman GL, Shellenberger TD, Ginsberg LE, Edeiken BS, El-Naggar AK, Sellin RV, et al. Approach and safety of comprehensive central compartment dissection in patients with recurrent papillary thyroid carcinoma. Head Neck. 2009;31:1152–63.
Davidson HC, Park BJ, Johnson JT. Papillary thyroid cancer: controversies in the management of neck metastasis. Laryngoscope. 2008;118:2161–5.
Carty SE, Cooper DS, Doherty GM, Dug QY, Kloos RT, Mandel SJ, et al. Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid. 2009;19:1153–8.
Rettenbacher L, Sungler P, Gmeiner D, Kassmann H, Galvan G. Detecting the sentinel lymph node in patients with differentiated thyroid carcinoma. Eur J Nucl Med. 2000;27:1399–401.
Sahin M, Yapici O, Dervisoglu A, Basoglu T, Canbaz F, Albayrak S, et al. Evaluation of lymphatic drainage of cold thyroid nodules with intratumoral injection of Tc-99m nanocolloid. Clin Nucl Med. 2001;26:602–5.
Gallowitsch HJ, Mikosch P, Kresnik E, Starlinger M, Lind P. Lymphoscintigraphy and gamma probe-guided surgery in papillary thyroid carcinoma: the sentinel lymph node concept in thyroid carcinoma. Clin Nucl Med. 1999;24:744–6.
Stoeckli SJ, Pfaltz M, Steinert H, Schmid S. Sentinel lymph node biopsy in thyroid tumors: a pilot study. Eur Arch Otorhinolaryngol. 2003;260:364–8.
Carcoforo P, Feggi L, Trasforini G, Lanzara S, Sortini D, Zulian V, et al. Use of preoperative lymphoscintigraphy and intraoperative gamma-probe detection for identification of the sentinel lymph node in patients with papillary thyroid carcinoma. Eur J Surg Oncol. 2007;33:1075–80.
Pelizzo MR, Rubello D, Boschin IM, Piotto A, Paggetta C, Toniato A, et al. Contribution of SLN investigation with 99mTc-nanocolloid in clinical staging of thyroid cancer: technical feasibility. Eur J Nucl Med Mol Imaging. 2007;34:934–8.
Lee SK, Choi JH, Lim HI, Kim WW, Kim SM, Choe JH, et al. Sentinel lymph node biopsy in papillary thyroid cancer: comparison study of blue dye method and combined radioisotope and blue dye method in papillary thyroid cancer. Eur J Surg Oncol. 2009;35:974–9.
Moo TA, Umunna B, Kato M, Butriago D, Kundel A, Lee JA, et al. Ipsilateral versus bilateral central neck lymph node dissection in papillary thyroid carcinoma. Ann Surg. 2009;250:403–8.
Abboud B, Sleilaty G, Braidy C, Zeineddine S, Ghorra C, Abadjian G, et al. Careful examination of thyroid specimen intraoperatively to reduce incidence of inadvertent parathyroidectomy during thyroid surgery. Arch Otolaryngol Head Neck Surg. 2007;133:1105–10.
Palestini N, Borasi A, Cestino L, Freddi M, Odasso C, Robecchi A. Is central neck dissection a safe procedure in the treatment of papillary thyroid cancer? Our experience. Langenbecks Arch Surg. 2008;393:693–8.
Cheah WK, Arici C, Ituarte PH, Siperstein AE, Duh QY, Clark OH. Complications of neck dissection for thyroid cancer. World J Surg. 2002;26:1013–6.
Son YI, Jeong HS, Baek CH, Chung MK, Ryu J, Chung JH, et al. Extent of prophylactic lymph node dissection in the central neck area of the patients with papillary thyroid carcinoma: comparison of limited versus comprehensive lymph node dissection in a 2-year safety study. Ann Surg Oncol. 2008;15:2020–6.
Williamson G, Pearse I. The anatomy (comparative and embryological) of the special thyroid lymph system, showing its relation to the thymus: with some physiological and clinical considerations that follow therefrom. Br J Surg. 2005:529–50.
Rubello D, Pelizzo MR, Al-Nahhas A, Salvatori M, O’Doherty MJ, Giuliano AE, et al. The role of sentinel lymph node biopsy in patients with differentiated thyroid carcinoma. Eur J Surg Oncol. 2006;32:917–21.
Acknowledgment
From the Gonda (Goldschmied) Research Laboratories of the John Wayne Cancer Institute at Saint John’s Health Center. Supported by funding from the Margie and Robert E. Petersen Foundation (Los Angeles, CA), QVC and the Fashion Footwear Association of New York Charitable Foundation (New York, NY), Mrs. Lois Rosen (Los Angeles, CA), and Maria Lucia and Fernando Diez Barroso (Beverly Hills, CA).
Author information
Authors and Affiliations
Corresponding author
Additional information
Presented in part at the Annual Meeting of the Society of Surgical Oncology, March 2010, St. Louis, MO.
Rights and permissions
About this article
Cite this article
Cunningham, D.K., Yao, K.A., Turner, R.R. et al. Sentinel Lymph Node Biopsy for Papillary Thyroid Cancer: 12 Years of Experience at a Single Institution. Ann Surg Oncol 17, 2970–2975 (2010). https://doi.org/10.1245/s10434-010-1141-x
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-010-1141-x